Virtual reality training to improve hand movement in Parkinson's disease
A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease: a Randomized Pilot Study
This study is testing whether a 4-week virtual reality training program can help improve hand movement and daily activities for people with Parkinson's disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 40 Years to 99 Years |
| Sex | All |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne) |
| Trial ID | NCT05965661 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a 4-week virtual reality-based upper limb training program designed to enhance dexterity in patients with Parkinson's disease. It employs a randomized, two-arm, single assessor blind, parallel design to compare the specific VR training with a control VR training that is less focused on dexterity. The study aims to evaluate improvements in hand coordination and the impact on activities of daily living, ultimately assessing the effect on the quality of life for participants. The research is conducted at a single center, Luzerner Kantonsspital.
Who should consider this trial
Good fit: Ideal candidates include adults aged 40 to 99 with confirmed Parkinson's disease and self-reported difficulties in dexterity.
Not a fit: Patients with severe cognitive impairments, psychiatric diseases, or significant visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this training could significantly improve hand dexterity and quality of life for patients with Parkinson's disease.
How similar studies have performed: While the use of virtual reality in rehabilitation is a growing field, this specific approach targeting dexterity in Parkinson's disease is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with confirmed PD, according to UK Brain bank Criteria * Hoehn \& Yahr Stadium I to IV * Age 40 to 99 years * written and signed informed consent * self-reported dexterous difficulties Exclusion Criteria: * MoCA \<21/30 * psychiatric disease * participation on other interventional trials * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. * severe visual impairment
Where this trial is running
Lucerne
- Luzerner Kantonsspital — Lucerne, Switzerland (Recruiting)
Study contacts
- Principal investigator: Tim Vanbellingen, Prof — Luzerner Kantonsspital
- Study coordinator: Cornelia Cox, MSc
- Email: cornelia.cox@luks.ch
- Phone: 041 205 56 80
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.